Vitreous albumin redox state in open-angle glaucoma patients and controls: a pilot study.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 24 07 2019
accepted: 30 12 2019
pubmed: 12 1 2020
medline: 11 3 2021
entrez: 12 1 2020
Statut: ppublish

Résumé

Numerous studies suggest that reactive oxygen species play a crucial role in the development of glaucoma. Since glaucoma patients exhibit posterior vitreous detachment earlier than controls, it has been suggested that reactive oxygen species-increased in glaucoma-also affect the vitreous. In the present study we evaluated the influence of open-angle glaucoma oxidative stress on the redox state of vitreous albumin. Albumin redox states of the vitreous and plasma were evaluated in 22 subjects-11 open-angle glaucoma patients and 11 controls-matched for age, gender, and vitreous state. According to the redox state of cysteine-34, albumin can be separated into: human mercaptalbumin (the thiol form), human nonmercaptalbumin1 (a reversible modification due to mild oxidation), and human nonmercaptalbumin2 (an irreversible modification due to severe oxidation). Albumin of both, the open-angle glaucoma group and the control group, was more oxidized in the vitreous compared to plasma. Furthermore, significantly higher human nonmercaptalbumin1 fractions were found in the vitreous of open-angle glaucoma patients compared to controls. No significant differences were found in the plasma albumin fractions between the groups. Our results support the hypothesis that oxidative stress plays a crucial role in open-angle glaucoma and that reactive oxygen species in glaucomatous eyes may also affect the vitreous.

Identifiants

pubmed: 31925660
doi: 10.1007/s10792-019-01268-5
pii: 10.1007/s10792-019-01268-5
doi:

Substances chimiques

Albumins 0
Reactive Oxygen Species 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1006

Références

J Glaucoma. 2007 May;16(3):334-43
pubmed: 17438430
Invest Ophthalmol Vis Sci. 1979 Oct;18(10):1000-18
pubmed: 225285
Prog Retin Eye Res. 2006 Sep;25(5):490-513
pubmed: 16962364
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5251-8
pubmed: 19516005
PLoS One. 2012;7(11):e49680
pubmed: 23189153
Free Radic Biol Med. 2005 Aug 1;39(3):365-73
pubmed: 15993335
Am J Med. 2003 Jun 1;114(8):638-46
pubmed: 12798451
Biochim Biophys Acta. 2008 Jul-Aug;1782(7-8):469-73
pubmed: 18498776
Acta Ophthalmol. 2011 Mar;89(2):e174-9
pubmed: 20064117
Redox Biol. 2016 Oct;9:100-103
pubmed: 27454767
Surv Ophthalmol. 2010 Mar-Apr;55(2):108-33
pubmed: 20159228
Free Radic Biol Med. 2008 Aug 15;45(4):367-76
pubmed: 18489911
J Pharmacol Exp Ther. 2000 Dec;295(3):1022-30
pubmed: 11082437
Naunyn Schmiedebergs Arch Pharmacol. 2018 Jan;391(1):51-58
pubmed: 29080912
Int J Mol Med. 2016 Oct;38(4):995-1002
pubmed: 27572245
Curr Eye Res. 2011 Aug;36(8):713-8
pubmed: 21780920
Curr Eye Res. 2019 Aug;44(8):856-862
pubmed: 30884982
Br J Pharmacol. 2007 Jul;151(5):580-90
pubmed: 17471184
J Pharmacol Exp Ther. 2013 Mar;344(3):637-45
pubmed: 23249625
Arch Ophthalmol. 2009 Apr;127(4):475-82
pubmed: 19365028
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4872-80
pubmed: 18971427
Saudi Med J. 2015 Jun;36(6):671-7
pubmed: 25987108
Arch Ophthalmol. 2005 Apr;123(4):458-63
pubmed: 15824217
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Free Radic Biol Med. 2020 Jan;146:257-263
pubmed: 31705958
Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1849-53
pubmed: 8759353
Exp Eye Res. 2007 Mar;84(3):389-99
pubmed: 17196589
Methods Enzymol. 2010;474:181-95
pubmed: 20609911
PLoS One. 2016 Dec 1;11(12):e0166915
pubmed: 27907028
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4594-9
pubmed: 16303954
Acta Ophthalmol. 2017 May;95(3):276-280
pubmed: 27966831

Auteurs

Christoph Schwab (C)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Margret Paar (M)

Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Neue Stiftingtalstraße 6, 8010, Graz, Austria. margret.paar@medunigraz.at.

Vera Heike Fengler (VH)

Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Neue Stiftingtalstraße 6, 8010, Graz, Austria.

Ewald Lindner (E)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Anton Haas (A)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Domagoj Ivastinovic (D)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Gerald Seidel (G)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Martin Weger (M)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Andreas Wedrich (A)

Department of Ophthalmology, Medical University of Graz, Auenbruggerplatz 4, 8036, Graz, Austria.

Karl Oettl (K)

Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Neue Stiftingtalstraße 6, 8010, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH